Literature DB >> 25180224

Antibody response to DNA vaccine against H5N1 avian influenza virus in broilers immunized according to three schedules.

Anna Stachyra1, Anna Góra-Sochacka1, Włodzimierz Zagórski-Ostoja1, Ewelina Król2, Agnieszka Sirko1.   

Abstract

Broiler type chickens were immunized intramuscularly with a DNA vaccine encoding hemagglutinin (HA) from H5N1 avian influenza virus. The chickens were divided into four groups: control group which was not immunized, a group which obtained only one dose, and two groups which were immunized twice, one group with a boost two weeks after the priming and the other four weeks. Blood samples were collected at several time points and the dynamics of the humoral response to the vaccine was studied. High level of anti-HA antibodies was detected only in the last two groups, that is in chickens immunized according to the prime-boost strategy, regardless of the schedule. An additional interesting observation of this study was detection of the cross-reactivity of an anti-H5 HA positive serum with H5N2 and H1N1 viruses, suggesting that the DNA vaccine tested can induce antibodies of a broad specificity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25180224

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  2 in total

1.  Effective usage of cationic derivatives of polyprenols as carriers of DNA vaccines against influenza virus.

Authors:  Anna Stachyra; Monika Rak; Patrycja Redkiewicz; Zbigniew Madeja; Katarzyna Gawarecka; Tadeusz Chojnacki; Ewa Świeżewska; Marek Masnyk; Marek Chmielewski; Agnieszka Sirko; Anna Góra-Sochacka
Journal:  Virol J       Date:  2017-09-02       Impact factor: 4.099

2.  Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens.

Authors:  Anna Stachyra; Patrycja Redkiewicz; Piotr Kosson; Anna Protasiuk; Anna Góra-Sochacka; Grzegorz Kudla; Agnieszka Sirko
Journal:  Virol J       Date:  2016-08-26       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.